Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (151-160 of 385) with videos related to

Pageof 39
Sort By:
Blood|September 23, 2011
High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patientsSylvie M Noordermeer, Mathijs A Sanders, Christian Gilissen, et al.
Haematologica|September 2, 2011
Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemiaAnnika C Russ, Sandrine Sander, Sonja C Lück, et al.
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
The Journal of Clinical Investigation|March 10, 2007
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisClaudia Scholl, Dimple Bansal, Konstanze Döhner, et al.
Molecular Cancer|August 19, 2022
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemiaYanan Zhai, Prashant Singh, Anna Dolnik, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Haematologica|October 5, 2019
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitisChristopher Maximilian Arends, Marlene Weiss, Friederike Christen, et al.
International Journal of Cancer|April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigensVanessa Schneider, Lu Zhang, Markus Rojewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplicationPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Transplantation|June 18, 2019
Cytotoxic Effects of Rabbit Anti-thymocyte Globulin Preparations on Primary Human Thymic Epithelial CellsEva M Kaebisch, Mi-Young Cho, Young-Seong Oh, et al.
Pageof 39

Showing results (151-160 of 385) with videos related to

Sort By:
Pageof 39
Blood|September 23, 2011
High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patientsSylvie M Noordermeer, Mathijs A Sanders, Christian Gilissen, et al.
Haematologica|September 2, 2011
Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemiaAnnika C Russ, Sandrine Sander, Sonja C Lück, et al.
Molecular Cancer|September 26, 2024
A high proportion of germline variants in pediatric chronic myeloid leukemiaManuela Krumbholz, Anna Dolnik, Eric Sträng, et al.
The Journal of Clinical Investigation|March 10, 2007
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisClaudia Scholl, Dimple Bansal, Konstanze Döhner, et al.
Molecular Cancer|August 19, 2022
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemiaYanan Zhai, Prashant Singh, Anna Dolnik, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Haematologica|October 5, 2019
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitisChristopher Maximilian Arends, Marlene Weiss, Friederike Christen, et al.
International Journal of Cancer|April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigensVanessa Schneider, Lu Zhang, Markus Rojewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplicationPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Transplantation|June 18, 2019
Cytotoxic Effects of Rabbit Anti-thymocyte Globulin Preparations on Primary Human Thymic Epithelial CellsEva M Kaebisch, Mi-Young Cho, Young-Seong Oh, et al.
Pageof 39